International Journal of Clinical Pathology and Diagnosis (ISSN: 2577-2139)

Case Report

Chordoid Glioma of Third Ventricle: About an Extensive and Rapidly Progressive Presentation

Hafsa Elouazzani,1,3* Sabrine Derquaoui,1,3 Hicham Belghiti,1,3 Ismail Boujida,1,3 Yasaad Ouadghiri,2,3 Zakaria Chandide Tlemcani,2,3 Yassir Arkha,2,3 Abdessamad Elouahabi,2,3 Nadia Cherradi1,3

1Department of Pathology HSR, Ibn Sina University Hospital Center Rabat, Morocco

2Department of Neurosurgery HSR, Ibn Sina University Hospital Center Rabat, Morocco

3Faculty of Medicine and Pharmacy, Mohammed 5 University, Rabat, Morocco

Corresponding Author*:

Received Date: 27 August, 2021

Accepted Date: 02 September, 2021

Published Date: 08 September, 2021


Chordoid glioma is a rare tumor of the Third Ventricle (V3), representing a very distinct clinico-pathological entity in the WHO classification of central nervous tumors, who classified it as grade II [1]. It has usually a slow growing. In this paper, we report the case of a rapidly progressive and lethal Chordoid Glioma (CG) in 48-year-old Moroccan a women. The rarity and the morphological similarities of this neoplasm with other suprasellar tumors constitute a challenge for the pathologist especially in extemporaneous condition, which complicates the diagnosis and the management.

Keywords: Chordoid glioma; Third ventricle; Low grade; Poor outcome

Abbreviations: CG: Chordoid Glioma; V3: Third Ventricle; WHO: World Health Organisation; GFAP: Glial Fibrillary Acidic Protein; CD34: Cluster Differentiation 34; EMA: Epithelial Membrane Antigen; TTF-1: Thyroid Transcription Factor-1; MRI: Magnetic Resonance Imaging